Rapid Clinical Improvement with Pentoxifylline in Pigmented Purpuric Dermatosis: A Case Report and UV-F Dermoscopy Findings
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Pigmented purpuric dermatoses (PPD) are chronic capillaritides characterized by petechiae, purpura, and brown macules.We present a biopsy-confirmed case of Schamberg disease with rapid clinical improvement following a 2-week course of oral pentoxifylline.A 25-year-old woman presented with an approximately 5-year history of recurrent asymptomatic petechial eruptions affecting the upper and lower extremities.Dermoscopy demonstrated reddish, round-to-oval globules and dots on a brownish background.Ultraviolet-induced fluorescence (UV-F) dermoscopy enhanced the visibility of active petechial foci and assisted in selecting an optimal biopsy site.Histopathology revealed a superficial perivascular lymphocytic infiltrate with focal erythrocyte extravasation and pigment-laden macrophages in the papillary dermis; features of leukocytoclastic vasculitis were absent.After failure of topical high-potency corticosteroids and topical calcineurin inhibitors, controlled-release pentoxifylline 600 mg once daily was initiated.Near-complete clinical resolution was observed by day 14.Treatment was discontinued because of nausea and vomiting, and remission persisted at 2-month follow-up.This case suggests that pentoxifylline may be associated with early clinical improvement in selected patients with PPD and highlights UV-F dermoscopy as a practical adjunct for identifying active purpuric foci and selecting a biopsy site.
Fields of Study & Subjects
Autoimmune and Inflammatory Disorders
Vasculitis and related conditions
Dermatological and COVID-19 studies
Publication details
- Journal / source
- Turkish Journal of Dermatology
- Publication date
- 27 March 2026
- Language
- EN